Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23)
Reviewed by
Dr Rose Hughes
on
Tuesday, November 18, 2025
Rating:
5
Fire sale of BMWs backfires: Hague court rejects exhaustion defence
Reviewed by
Oliver Fairhurst
on
Monday, November 17, 2025
Rating:
5
EPO pharma case law trends 2025: Antibodies and biologics
Reviewed by
Dr Rose Hughes
on
Monday, November 17, 2025
Rating:
5
Can infringement be avoided by performing part of a diagnostic method claim in another jurisdiction?
Reviewed by
Dr Claire Gregg
on
Monday, November 17, 2025
Rating:
5
Sunday Surprises
Reviewed by
Verónica Rodríguez Arguijo
on
Sunday, November 16, 2025
Rating:
5
Best-case scenario for Puma?
Reviewed by
Söğüt Atilla-Aydın
on
Sunday, November 16, 2025
Rating:
5
[Guest Book Review] Publishers’ Rights and Copyright Law
Reviewed by
Jocelyn Bosse
on
Friday, November 14, 2025
Rating:
5
Freedom of expression is only "due cause" if targeted at the trade mark holder, says Advocate General in IKEA-PLAN opinion
Reviewed by
Jocelyn Bosse
on
Thursday, November 13, 2025
Rating:
5
Never Too Late: If you missed the IPKat last week!
Reviewed by
Kliment Markov
on
Thursday, November 13, 2025
Rating:
5
Why you still can't have your cake and eat it too: "best method" lives on in Australia
Reviewed by
Dr Claire Gregg
on
Wednesday, November 12, 2025
Rating:
5